Consistently, there was a significant negative correlation between hepatic cyclin D1 gene expression and cell death and a significant positive correlation between cyclin D1 expression and cancer metastatic capability (as assessed by the MMP-2:TIMP-1 ratio). This evidence concerns the gene MMP2 and cancer.